6 ARDS Patients Treated With Allogeneic Cardiac Stem Cells

Capricor - 1 minute read

  • 100% survival rate in 6 patients during 1 month of treatment
  • Treated with Capricor’s stem cell therapy CAP-1002
  • An allogeneic cardiac stem cell therapy (CDCs)
  • CDCs modulate various inflammatory cytokines and help regulate the immune response. Pending publication

“We look forward to continuing to treat additional patients under our recently approved expanded access program Investigational New Drug application,”

 Dr. Linda Marbán, Ph.D., CEO, Capricor

12 months ago from Capricor's press release via